This federal contract award, valued at $6,588.71, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a firm-fixed-price delivery order for the provision of ENBREL 50 MG/ML SURECLICK medication. The contract has an ultimate completion date of November 20, 2024.
Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's ECAT Generation V Program, allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This latest award is part of the larger IDC and does not have a set-aside designation.
Generated 2/18/25, 1:34 PM